Tue, May 14, 2024
Mon, May 13, 2024
Fri, May 10, 2024

David Amsellem Reiterated (TEVA) at Buy with Increased Target to $20 on, May 13th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-20-on-may-13th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Amsellem of Piper Sandler, Reiterated "Teva Pharmaceutical Industries Limited" (TEVA) at Buy with Increased Target from $19 to $20 on, May 13th, 2024.

David has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Schott of "JP Morgan" Upgraded from Sell to Hold and Held Target at $14 on, Friday, March 8th, 2024
  • Nathan Rich of "Goldman Sachs" Maintained at Hold with Increased Target to $11 on, Monday, February 5th, 2024


These are the ratings of the 2 analyists that currently disagree with David


  • Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $20 on, Thursday, May 9th, 2024
  • Glen Santangelo of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $14 on, Tuesday, January 23rd, 2024

Publication Contributing Sources